Two Sigma Investments’s Xenon Pharmaceuticals XENE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-236,983
Closed -$7.95M 3527
2025
Q1
$7.95M Sell
236,983
-36,369
-13% -$1.22M 0.02% 833
2024
Q4
$10.7M Buy
273,352
+29,773
+12% +$1.17M 0.02% 685
2024
Q3
$9.59M Buy
243,579
+48,450
+25% +$1.91M 0.02% 738
2024
Q2
$7.61M Sell
195,129
-79,497
-29% -$3.1M 0.02% 770
2024
Q1
$11.8M Sell
274,626
-65,389
-19% -$2.81M 0.03% 561
2023
Q4
$15.7M Buy
340,015
+259,382
+322% +$11.9M 0.04% 460
2023
Q3
$2.75M Buy
80,633
+62,000
+333% +$2.12M 0.01% 1145
2023
Q2
$717K Buy
18,633
+7,179
+63% +$276K ﹤0.01% 2075
2023
Q1
$410K Buy
+11,454
New +$410K ﹤0.01% 2220
2022
Q4
Sell
-55,974
Closed -$2.02M 3053
2022
Q3
$2.02M Buy
+55,974
New +$2.02M 0.01% 1110
2022
Q2
Sell
-232,650
Closed -$7.11M 2924
2022
Q1
$7.11M Sell
232,650
-45,693
-16% -$1.4M 0.02% 740
2021
Q4
$8.7M Buy
278,343
+108,667
+64% +$3.39M 0.02% 694
2021
Q3
$2.59M Buy
169,676
+84,458
+99% +$1.29M 0.01% 1218
2021
Q2
$1.59M Buy
85,218
+8,512
+11% +$159K ﹤0.01% 1464
2021
Q1
$1.37M Buy
76,706
+26,145
+52% +$468K ﹤0.01% 1455
2020
Q4
$778K Buy
50,561
+576
+1% +$8.86K ﹤0.01% 1441
2020
Q3
$553K Sell
49,985
-70,130
-58% -$776K ﹤0.01% 1376
2020
Q2
$1.51M Buy
120,115
+31,510
+36% +$395K 0.01% 988
2020
Q1
$1.01M Buy
88,605
+11,788
+15% +$134K 0.01% 953
2019
Q4
$1.01M Buy
+76,817
New +$1.01M ﹤0.01% 1414
2019
Q2
Sell
-58,149
Closed -$591K 2474
2019
Q1
$591K Sell
58,149
-142,112
-71% -$1.44M ﹤0.01% 1596
2018
Q4
$1.26M Buy
200,261
+123,676
+161% +$781K ﹤0.01% 1216
2018
Q3
$1.01M Buy
+76,585
New +$1.01M ﹤0.01% 1364